Research ArticleArticle
What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout
Jeremy Holyer, Andrea Garcia-Guillen, William J. Taylor, Angelo L. Gaffo, Merryn Gott, Julia Slark, Anne Horne, Isabel Su, Nicola Dalbeth and Sarah Stewart
The Journal of Rheumatology September 2021, jrheum.210476; DOI: https://doi.org/10.3899/jrheum.210476
Jeremy Holyer
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Andrea Garcia-Guillen
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
William J. Taylor
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Angelo L. Gaffo
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Merryn Gott
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Julia Slark
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Anne Horne
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Isabel Su
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Nicola Dalbeth
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Sarah Stewart
JH was supported by a University of Auckland Summer Student Scholarship. J. Holyer, medical student, A. Garcia-Guillen, MD, M. Gott, PhD, J. Slark, PhD, A. Horne, MBChB, I. Su, BSc, N. Dalbeth, MBChB, MD, FRACP, S. Stewart, PhD, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand; W.J. Taylor, MBChB, PhD, FRACP, FAFRM, Department of Medicine, University of Otago, Wellington, New Zealand; A.L. Gaffo, MD, MSPH, FACP, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA. ND reports grants and personal fees from AstraZeneca; personal fees from Horizon, AbbVie, AstraZeneca, Jansen, Hengrui, Dyve Biosciences, Selecta, and Arthrosi; and grants from Amgen and AstraZeneca outside the submitted work. The other authors declare no competing interests relevant to this article. Address correspondence to Dr. S. Stewart, Hospital de la Santa Creu i Sant Pau, Carrer de Sant Quinti, 89, 08041 Barcelona, Spain. Email: sarah.stewart@auckland.ac.nz. Accepted for publication August 11, 2021.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout
Jeremy Holyer, Andrea Garcia-Guillen, William J. Taylor, Angelo L. Gaffo, Merryn Gott, Julia Slark, Anne Horne, Isabel Su, Nicola Dalbeth, Sarah Stewart
The Journal of Rheumatology Sep 2021, jrheum.210476; DOI: 10.3899/jrheum.210476
What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout
Jeremy Holyer, Andrea Garcia-Guillen, William J. Taylor, Angelo L. Gaffo, Merryn Gott, Julia Slark, Anne Horne, Isabel Su, Nicola Dalbeth, Sarah Stewart
The Journal of Rheumatology Sep 2021, jrheum.210476; DOI: 10.3899/jrheum.210476